[1]
Prabhudesai, D.P. et al. 2021. Efficacy and Safety of Levonadifloxacin in the Management of Community-Acquired Bacterial Pneumonia (CABP): Findings of a Retrospective, Real-World, Multi-centre Study. International Journal of Innovative Research in Medical Science. 6, 12 (Dec. 2021), 919–925. DOI:https://doi.org/10.23958/ijirms/vol06-i12/1295.